Cargando…
MOSPD2 is a therapeutic target for the treatment of CNS inflammation
In multiple sclerosis and experimental autoimmune encephalomyelitis (EAE), myeloid cells comprise a major part of the inflammatory infiltrate in the central nervous system (CNS). We previously described that motile sperm domain‐containing protein 2 (MOSPD2) is expressed on human myeloid cells and re...
Autores principales: | Yacov, N., Kafri, P., Salem, Y., Propheta‐Meiran, O., Feldman, B., Breitbart, E., Mendel, I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366745/ https://www.ncbi.nlm.nih.gov/pubmed/32353176 http://dx.doi.org/10.1111/cei.13448 |
Ejemplares similares
-
Newly characterized motile sperm domain‐containing protein 2 promotes human breast cancer metastasis
por: Salem, Yaniv, et al.
Publicado: (2018) -
PEPITEM modulates leukocyte trafficking to reduce obesity-induced inflammation
por: Pezhman, Laleh, et al.
Publicado: (2023) -
Mycobacterium leprae intracellular survival relies on cholesterol accumulation in infected macrophages: a potential target for new drugs for leprosy treatment
por: Mattos, Katherine A, et al.
Publicado: (2014) -
Notch signalling is a potential resistance mechanism of progenitor cells within patient‐derived prostate cultures following ROS‐inducing treatments
por: Packer, John R., et al.
Publicado: (2019) -
Acceptability and safety of thermal ablation for the treatment of precancerous cervical lesions in Honduras
por: Sandoval, Manuel, et al.
Publicado: (2019)